Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,620 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06525909Recruiting
Immune status in chronic hepatitis B
This study looks at how the immune system changes over time in people with chronic hepatitis B. It will help doctors better understand the stages of the disease to guide treatment decisions.
Wuhan, HubeiAges 18–50 - NCT06526312Recruiting
Health program for teens with higher BMI
This study tests a program in primary care to help teenagers improve their lifelong health. It is designed for teens whose weight is higher than average for their age and gender.
Phoenix, ArizonaAges 2–99 - NCT06526676Recruiting
Custom stent grafts for aortic aneurysms in high-risk patients
This study tests custom-fitted stent grafts for patients with aortic aneurysms who are not good candidates for open surgery or standard stent grafts. The grafts are modified by the surgeon during the procedure to match your specific anatomy.
Los Angeles, CaliforniaAges 18 years+ - NCT06527495RecruitingPhase 1/Phase 2
Genetics of Sorafenib in Liver Cancer Patients
This trial tests whether the way your body processes the drug sorafenib (used for liver cancer) affects its safety and effectiveness. It aims to find the best dose for patients based on their genetics, which could lead to better treatment outcomes.
Shibīn al Kawm, MenoufiaAges 18–80 - NCT06527547Recruiting
Ear acupuncture for sleep problems in rheumatoid arthritis
This trial tests if a gentle, non-invasive ear acupuncture device can improve sleep in people with rheumatoid arthritis (RA). If you have RA, poor sleep, and your disease is under control, this study might be a good fit.
Beijing, Beijing MunicipalityAges 18–72 - NCT06527560RecruitingPhase 4
Comparing oral vs. IV cefuroxime for kidney infection in pregnancy
This study compares a pill form of the antibiotic cefuroxime to an IV (intravenous) version for treating kidney infections during pregnancy. It aims to see if the oral option works just as well, which could make treatment easier and more comfortable for pregnant women.
Porto Alegre, Rio Grande do SulAges 18–48 - NCT06527807Recruiting
Stroke in pregnancy and after birth study
This study looks at how stroke affects women who are pregnant or have recently given birth, and how it may affect their babies. It aims to understand the risks and outcomes for both mothers and children.
Beijing, Beijing MunicipalityAges Any age - NCT06528444RecruitingPhase 3
Dexamethasone vs placebo for severe flu patients
This trial tests whether dexamethasone (a steroid) can help people hospitalized with severe flu recover faster. It is for adults who are already taking Tamiflu and do not have other serious infections like COVID-19.
AlicanteAges 18–100 - NCT06528431RecruitingPhase 4
Personalized tapering of adalimumab for rheumatoid arthritis
This study tests if checking the amount of adalimumab (a biologic drug) in your blood can help doctors safely lower your dose. If you have had rheumatoid arthritis under control for at least 6 months, this trial may help you take less medication while keeping symptoms away.
Caluire-et-CuireAges 18 years+ - NCT06528639Recruiting
Exercise program to reduce heart and metabolic risk
This study tests whether a personalized exercise plan guided by a special breathing test can help lower your risk for heart disease and related conditions. You may qualify if you are not very active and have early signs of metabolic syndrome like a larger waist, higher blood sugar, or higher blood pressure.
Beijing, Beijing MunicipalityAges 30–65 - NCT06529094Recruiting
Preventing pressure injuries in spinal cord injury
This study tests a decision-support tool to help prevent pressure injuries (bedsores) in veterans with spinal cord injury. It may be a good fit if you see a SCI clinic provider and can fill out a short survey.
Long Beach, CaliforniaAges 18 years+ - NCT06529913Recruiting
Metals, pollutants, and risk of allergies
This study looks at whether heavy metals, nanoparticles, and other pollutants in the environment increase the risk of allergic diseases like contact dermatitis. If you have a metal allergy or are a healthy adult, you may help researchers understand how these exposures affect your health.
BolognaAges 18 years+ - NCT06530004Recruiting
Rituximab for childhood nephrotic syndrome: a follow-up study
This study follows children with nephrotic syndrome (a kidney condition causing swelling) who are being treated for the first time with rituximab. It aims to see how well the medication works long-term.
Xiamen, FujianAges 1–18 - NCT06530641RecruitingPhase 4
Comparing heart protection solutions during major heart surgery
This trial compares two types of cardioplegia (a solution that stops your heart during surgery) to see which one leads to better outcomes. It is for adults undergoing major heart surgery with a heart-lung machine.
Madrid, MadridAges 18 years+ - NCT06532006RecruitingPhase 3
HLX22 plus trastuzumab and chemo for HER2+ stomach cancer
This trial tests adding a new drug, HLX22, to the standard combination of trastuzumab and chemotherapy for people with HER2-positive stomach or gastroesophageal junction cancer that hasn't been treated yet. The goal is to see if this three-drug mix works better than the usual two-drug approach.
Anaheim, CaliforniaAges 18 years+ - NCT06532214Recruiting
Liver surgery recovery study
This study looks at what happens after liver surgery. It will help doctors better understand complications and how to improve recovery for people who had their liver removed.
Guangzhou, GuangdongAges 18–80 - NCT06533358RecruitingPhase 2
Testing MT1002 for heart attack patients getting a stent
This study tests an investigational medicine called MT1002 in people who have had a heart attack and are about to get a stent (PCI). The goal is to see if MT1002 helps prevent further heart problems.
Beijing, Beijing MunicipalityAges 18–85 - NCT06533371Recruiting
Ultrasound for emphysema in COPD and lung cancer
This study uses ultrasound (a safe, painless sound wave test) to check for emphysema (damaged air sacs in the lungs) in people with COPD or those being screened for lung cancer. It aims to see if ultrasound can replace the need for CT scans.
Acquaviva delle FontiAges 18 years+ - NCT06533410Recruiting
Testing a new Chinese pain scale for fibromyalgia diagnosis
This study tests a new Chinese questionnaire to help doctors diagnose fibromyalgia more accurately. It is for people with long-lasting, widespread pain who can fill out a simple form.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06534463Recruiting
MZL patient registry study
This study is a registry that collects information on Chinese patients with marginal zone lymphoma. It helps doctors learn more about how MZL behaves and how it is treated.
Shanghai, Shanghai MunicipalityAges 14 years+ - NCT06534723RecruitingPhase 3
Wujia Yizhi granules for mild-to-moderate Alzheimer's
This trial tests if a Chinese herbal granule (Wujia Yizhi) can help people with mild-to-moderate Alzheimer's dementia. It is for patients who have memory problems for at least 6 months and meet specific Alzheimer's biomarker criteria.
Fuzhou, FujianAges 50–80 - NCT06534762RecruitingPhase 2
Miraberon for advanced solid tumors (first treatment)
This study tests a drug called Miraberon for people with advanced solid tumors that have not yet been treated with chemotherapy or other cancer drugs. The goal is to see if Miraberon can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18–65 - NCT06535113Recruiting
Inflammation and treatment response in AML
This study looks at how inflammation (the body's response to injury or infection) affects treatment outcomes in people with acute myeloid leukemia (AML). If you have a new diagnosis or have stored samples from a past diagnosis, you may help researchers understand why some people respond better to therapy.
Reggio Calabria, CalabriaAges 18 years+ - NCT06535308RecruitingPhase 1
Testing a new Alzheimer's drug for moderate disease
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Seoul, Jongno-guAges 19–45
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,620 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.